Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Digestion ; 94(2): 114-122, 2016.
Article in English | MEDLINE | ID: mdl-27705965

ABSTRACT

BACKGROUND/AIM: The assessment of advanced chronic liver disease (ACLD) is a prerequisite for therapy and surveillance in patients with chronic hepatitis C infection. Mini-laparoscopy-assisted liver biopsies facilitate both histological and macroscopical evaluation of liver fibrosis. This study is aimed at investigating the prognostic significance of the laparoscopic assessment for the cumulative incidence of ACLD-related events. PATIENTS AND METHODS: We performed a single center, retrospective analysis of 94 patients with either macroscopically or/and microscopically assessed advanced fibrosis/cirrhosis caused by chronic hepatitis C infection. The patients' data, the respective laboratory results, and follow-up period were evaluated in the outpatient clinic. RESULTS: The group with both macro- and microscopic diagnosed ACLD showed a significantly higher number of decompensating events (n = 7) compared with the other 2 groups (n = 0 in the group with only histological and n = 1 in the group with only laparoscopic diagnosis of advanced liver disease). The results were not affected by the successful treatment of the hepatitis C virus. In the Cox-regression analysis, the spleen size (>120 mm) was significantly associated with the incidence of ACLD-related events. CONCLUSIONS: Assessment of ACLD in chronic hepatitis C by mini-laparoscopy-assisted liver biopsies may facilitate the selection of patients with a poor prognosis, irrespective of achieving a sustained virological response following treatment. Follow-up of these patients should be intensified to treat decompensation early.


Subject(s)
Hepatitis C, Chronic/complications , Hepatitis C, Chronic/pathology , Laparoscopy/methods , Liver Cirrhosis/epidemiology , Liver Cirrhosis/pathology , Liver/pathology , Adult , Aged , Antiviral Agents/therapeutic use , Biopsy/methods , Female , Follow-Up Studies , Germany/epidemiology , Hepacivirus/drug effects , Hepacivirus/isolation & purification , Hepatitis C, Chronic/drug therapy , Humans , Incidence , Liver Cirrhosis/virology , Male , Middle Aged , Prognosis , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...